CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Corticosteroids - topical (skin), nose, and eyes - Management
How do I minimize the risks of adverse effects in people using intranasal corticosteroids?
- To minimize the adverse effects of intranasal corticosteroids:
- Prescribe a nasal spray instead of drops. If nasal drops are indicated or preferred, ensure that they are used correctly.
- Prescribe the weakest potency possible, for the shortest period of time.
- In children receiving prolonged treatment with high doses of intranasal corticosteroids (especially drops):
- Monitor height regularly, using a growth chart. Any slowing of growth rate should prompt a reduction in dose if possible, or referral to a specialist, or both.
© NHS Institute for Innovation and Improvement